SC
SILK

Scholtz & Company’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Scholtz & Company’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-37,517
Closed -$2.36M – 84
2020
Q4 		$2.36M Sell
37,517
-6,578
-15% -$408K 0.92% 38
2020
Q3 		$2.96M Sell
44,095
-1,645
-4% -$89.8K 1.29% 32
2020
Q2 		$1.92M Buy
45,740
+21,570
+89% +$828K 0.96% 34
2020
Q1 		$761K Buy
+24,170
New +$968K 0.58% 36

Other funds holding SILK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Scholtz & Company's SILK Position: Q1 2021 in Review

Scholtz & Company sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q1 2021, closing a stake of 37,517 shares — an estimated $2.36M sold.

Scholtz & Company first reported a position in SILK in Q1 2020 and held it in 4 quarters. The position peaked at $2.96M in Q3 2020. 172 funds tracked by Wall St. Rank hold SILK as of Q1 2021.

  • Scholtz & Company reported no remaining Silk Road Medical, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Scholtz & Company sold 37,517 Silk Road Medical, Inc. Common Stock shares in Q1 2021, an estimated $2.36M.
  • Scholtz & Company first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • Scholtz & Company's Silk Road Medical, Inc. Common Stock position peaked at $2.96M in Q3 2020.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2021.

Based on Scholtz & Company's 13F filing for Q1 2021, filed 17 May 2021.